Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB06674_DB08895_nanopub.RAo-_7-NiVZJFnEsCLIWgevUh4TQKMFuH6XyqbIH3w9TE#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB06674_DB08895 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06674_DB08895 label "DDI between golimumab and Tofacitinib - Golimumab, and other anti-TNF immunosuppressants, when used in combination with tofacitinib, may increase the serum concentration of tofacitinib, and increase tofacitinib associated side effects and immunosuppresion. It is recommended to avoid concurrent therapy. [drugbank_resource:DB06674_DB08895]" assertion.
- drugbank_resource:DB06674_DB08895 identifier "drugbank_resource:DB06674_DB08895" assertion.
- drugbank_resource:DB06674_DB08895 title "DDI between golimumab and Tofacitinib - Golimumab, and other anti-TNF immunosuppressants, when used in combination with tofacitinib, may increase the serum concentration of tofacitinib, and increase tofacitinib associated side effects and immunosuppresion. It is recommended to avoid concurrent therapy." assertion.
- drugbank:DB06674 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06674_DB08895 assertion.
- drugbank:DB08895 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06674_DB08895 assertion.